Huake Holding Biology Co Ltd, a camellia seed oil manufacturer, has filed Form F-1 Registration Statement on June 29, 2021 with the U.S. Securities and Exchange Commission to raise up to $20 million IPO. Pricing terms are yet to announce.
The company is an exempted company incorporated with limited liability engaging in the production and sales of camellia seed oil (“Camellia Oil”) products in China. They maintain a strong and expanding customer base through different channels of merchandising, including direct selling, sales exhibition, and franchising, etc.
The Lu'an City, China-based company was founded in 2011 and booked $15 million in sales for the 12 months ended September 30, 2020. It plans to list on the Nasdaq Capital Market under the symbol “HUAK.” Huake Holding Biology filed confidentially on June 29, 2021. The company has not yet named underwriters for the deal.
The company engages Hunter Taubman Fischer & Li LLC as US Securities Counsel, and Prager Metis CPAs, LLC as Independent Auditor.
#ipo #nasdaq #seedoil #HuakeHoldingBiology #china #camelliaoil
Hexcellence Consulting has experienced IPO consulting team focus on listing in US Stock Market,
namely NYSE, Nasdaq and OTC Markets.
Should you interested to list your company in US Stock Market,
please contact us at [email protected]
